Published 2 years ago • loading... • Updated 2 years ago

Pill made from freeze-dried faeces to be taken by liver disease patients in clinical trial

A clinical trial is being launched in the UK to test faecal transplants' effectiveness for treating advanced liver disease patients to reduce the likelihood of them getting infections.
The trial involves 300 patients receiving either freeze-dried stool capsules or a placebo tablet every three months for two years.
Liver disease kills around 40 people per day in the UK and is the third biggest cause of premature death among working-age people.

Insights by Ground AI

Does this summary seem wrong?

8 Articles

All

Left

Center

Right

Medical Xpress

Center

Fecal transplant trial provides hope for liver disease patients

The UK is to launch a clinical trial of a "poo transplant" that researchers believe could treat advanced liver disease and fight antimicrobial resistance.

2 years ago

Read Full Article

BBC News

Center

Liver disease: 'Poo transplant' treatment trial launched

Participants will consume capsules of dried faeces to see if they can improve gut health.

2 years ago·United Kingdom

Read Full Article

Sky News UK

Center

Pill made from freeze-dried faeces to be taken by liver disease patients in clinical trial

Around 300 people are expected to take part in the trial and will be randomly assigned either freeze-dried capsules made from human stools or placebo tablets every three months.

2 years ago·United Kingdom

Read Full Article

Evening Standard

Center

‘Poo transplant’ trial hope for ending killer liver disease

London scientists will launch a clinical trial of a transplant that they believe could help to treat advanced liver disease — the third biggest cause of death in adults of working age.

2 years ago·London, United Kingdom

Read Full Article

iNews

Center

How a 'poo transplant' trial could transform care for liver disease patients

The UK is to launch a national clinical trial of a 'poo transplant' that researchers believe could treat advanced liver disease and fight antimicrobial resistance.

2 years ago·London, United Kingdom

Read Full Article